Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10129245 | Translational Oncology | 2018 | 8 Pages |
Abstract
Autophagy is an intracellular self-degradative process that balances cell energy source and regulates tissue homeostasis. In physiological condition, autophagy funnels cytoplasmic constituents to autophagolysosomes for degradation and is an alternative way for cell-death behavior. Here, we inspected autophagy as a prosurvival mechanism essential for drug resistance in multiple myeloma (MM). Accordingly, autophagy inhibitors used in association to conventional anti-MM drugs might enforce the effect against resistant MM plasma cells and render autophagy a new therapeutic target.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
V. Desantis, I. Saltarella, A. Lamanuzzi, M.A. Mariggiò, V. Racanelli, Angelo Vacca, M.A. Frassanito,